Scientific Advisory Board

Scientific Advisory Board

University of Cincinnati, College of Medicine

Tenured Professor of Psychiatry

Jeffrey R. Strawn, MD, is the Dr. Henry and Amelia Nasrallah Endowed Professor in Psychiatric Neuroscience and Professor of Psychiatry at the University of Cincinnati. He serves as Associate Vice Chair of Research in the Department of Psychiatry & Behavioral Neuroscience and Co-Director of the NIH-funded Center for Clinical & Translational Science & Training. Dr. Strawn is an internationally recognized psychiatrist and psychopharmacologist whose research focuses on precision psychopharmacology for anxiety and related disorders. Continuously funded by the National Institutes of Health since 2010, his work integrates clinical pharmacology, pharmacogenetics, neurobiology, and translational neuroscience to improve treatment selection and optimize outcomes for children and adolescents with psychiatric disorders. His research has informed clinical practice guidelines, advanced personalized approaches to psychopharmacology, and contributed to the development of FDA-approved treatments for anxiety disorders.

He has authored nearly 300 peer-reviewed publications, cited more than 10,000 times, and co-authored six textbooks. In addition to his research, Dr. Strawn maintains an active clinical practice and is an award-winning educator and mentor. He is a Distinguished Fellow of the American Academy of Child & Adolescent Psychiatry and an elected Member of the American College of Neuropsychopharmacology.

Massachusetts General Hospital; Harvard Medical School

Chief, Neuroendocrine Unit; Professor of Medicine

Karen K. Miller, MD, is the Chief of the Neuroendocrine Unit at Massachusetts General Hospital, Director of the Mass General Brigham Pituitary Center, and a Professor of Medicine at Harvard Medical School. She is a practicing endocrinologist and a continuously NIH-funded physician-scientist who conducts clinical, translational, and fundamental research to advance the care of patients with pituitary disorders and studies the impact of hypothalamic and pituitary hormone dysregulation on body composition, bone, and brain.

She has authored more than 200 peer-reviewed publications. Awards in recognition of her work and mentorship include the Endocrine Society International Award for Excellence in Published Clinical Research in the Journal of Clinical Endocrinology and Metabolism and the Harvard Medical School William Silen Lifetime Achievement in Mentoring Award.

Texas Tech University School of Medicine; Private Practice

Clinical Professor at the Department of Psychiatry

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on the impact of substance abuse. He graduated from the School of Public Health in 1987 with a Master of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

UCSF, Sutter East Bay Medical Foundation

Clinical Professor, Obstetrics, Gynecology & Reproductive Sciences

Risa Kagan, MD, FACOG, CCD, MSCP, is a board-certified obstetrician-gynecologist and is a Clinical Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF. After many years in private practice in Berkeley, CA, she became a founding member of the Sutter East Bay Medical Group (SEBMG) and practiced gynecology and clinical research with the Sutter East Bay Medical Foundation. She is now a menopause consultant for SEBMG. Dr. Kagan was a principal investigator on women’s health clinical research trials when she was co-medical director of the Foundation for Osteoporosis Research and Education (FORE) in Oakland, CA, then subsequently did menopause related clinical research with the Sutter Health Research Institute Dr. Kagan has authored numerous publications in peer-reviewed journals and serves on the editorial board of Menopause. She is also an ad hoc reviewer for many other peer review journals.

She is a North American Menopause Society (NAMS) certified Menopause Practitioner (NCMP) and is certified by the International Society of Clinical Densitometry (CCD). She specializes in gynecology, with a special focus on menopause related health issues, bone and female sexual health, and female cancer survivorship. She is actively involved in several professional organizations, including NAMS, is a past Board Trustee, Scientific Program Chair and is on the current NAMS Scientific Program Committee. She is also an active member of the International Society for the Study of Women’s Sexual Health (ISSWSH) and the International Menopause Society (IMS) and is on the Medical and Scientific Advisory Board of American Bone Health (ABH).

Sweetgrass Psychiatry; The Medical University of South Carolina: MUSC

CEO/CMO; Affiliate Assistant Professor

Brittney Albright, MD, MPH, DABOM, is a Harvard-trained, triple board-certified psychiatrist with clinical expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at the nation’s top-ranked program, Massachusetts General Hospital and McLean Hospital, and a fellowship in addiction psychiatry at the Medical University of South Carolina, where she serves as an Affiliate Assistant Professor in the Department of Psychiatry & Behavioral Sciences. Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice with three locations.

Her research and academic work include numerous abstracts presented at national meetings and peer-reviewed manuscripts focused on innovative treatments, women’s health, and psychiatric education. A national speaker and consultant, she serves as President Elect of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including co-chair of Psych Congress Elevate and originator of the Private Practice Summit.

She firmly believes in collaborative, comprehensive treatment and the restoration of wellness in her patients and practices psychotherapy with expertise in mentalization based therapy and psychodynamic therapy. She also holds certifications in psychedelic assisted psychotherapy and transcranial magnetic stimulation.

Mass General Brigham (MGB); MGB Research Oversight Committee (ROC); Clinical Trials Network and Institute (CTNI)
Chairman

Chair; Co-Chair; Executive Director

Maurizio Fava, MD, is acknowledged as a world-renowned expert in depressive disorders and psychopharmacology. Dr. Fava is currently Director of the Division of Clinical Research of the Massachusetts General Hospital (MGH) Research Institute, Executive Vice Chair, Department of Psychiatry at MGH, and Executive Director of the MGH Clinical Trials Network and Institute (CTNI), as well as Slater Family Professor of Psychiatry at Harvard Medical School.

He has authored or co-authored more than 600 original articles published in medical journals with international circulation. The citation impact of his work is extremely high, as his articles have been cited more than 40,000 times in the literature. He has edited eight books, published more than 50 chapters and 600 abstracts, and has given more than 350 presentations at national and international meetings. Dr. Fava is the recipient of several awards and is on the editorial board of five international medical journals.

Columbia University; The Medical Research Network

Michael Liebowitz, MD, is a Columbia University psychiatrist and former director and founder of the Anxiety Disorders Clinic at the New York State Psychiatric Institute. He retired in 2006 as Director of the Anxiety Disorder Clinic, a position that he held since 1982, and is a member of the American Society of Clinical Psychopharmacology, the Anxiety Disorder Association of America Scientific Advisory Board, the American College of Neuropsychopharmacology and the American Psychiatric Association. He is also Managing Director of The Medical Research Network LLC and serves on the editorial board of Depression and Anxiety. Dr. Liebowitz has published numerous journal articles, books and chapters about psychiatry.

Corporate Excellence

These meaningful recognitions reflect Vistagen’s unwavering commitment to a purpose-driven culture and a workplace that champions employee mental health and well-being.